AU512626B2 - 4-Hydroxyphenylalkanolamine derivatives and preparation thereof - Google Patents

4-Hydroxyphenylalkanolamine derivatives and preparation thereof

Info

Publication number
AU512626B2
AU512626B2 AU26368/77A AU2636877A AU512626B2 AU 512626 B2 AU512626 B2 AU 512626B2 AU 26368/77 A AU26368/77 A AU 26368/77A AU 2636877 A AU2636877 A AU 2636877A AU 512626 B2 AU512626 B2 AU 512626B2
Authority
AU
Australia
Prior art keywords
hydroxyphenylalkanolamine
derivatives
preparation
hydroxyphenylalkanolamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU26368/77A
Other languages
English (en)
Other versions
AU2636877A (en
Inventor
RE Penton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterling Delia Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of AU2636877A publication Critical patent/AU2636877A/en
Application granted granted Critical
Publication of AU512626B2 publication Critical patent/AU512626B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26368/77A 1976-06-25 1977-06-23 4-Hydroxyphenylalkanolamine derivatives and preparation thereof Expired AU512626B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69985676A 1976-06-25 1976-06-25
USUS699856 1976-06-25
US80337277A 1977-06-03 1977-06-03
USUS803372 1977-06-03

Publications (2)

Publication Number Publication Date
AU2636877A AU2636877A (en) 1979-01-04
AU512626B2 true AU512626B2 (en) 1980-10-23

Family

ID=27106508

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26368/77A Expired AU512626B2 (en) 1976-06-25 1977-06-23 4-Hydroxyphenylalkanolamine derivatives and preparation thereof

Country Status (21)

Country Link
JP (1) JPS5321134A (de)
AR (2) AR220896A1 (de)
AT (1) AT354420B (de)
AU (1) AU512626B2 (de)
CA (1) CA1091245A (de)
CH (2) CH627447A5 (de)
DE (1) DE2728641A1 (de)
DK (1) DK146386C (de)
ES (1) ES460040A1 (de)
FI (1) FI771976A (de)
FR (1) FR2366272A1 (de)
GB (1) GB1544872A (de)
HK (1) HK60184A (de)
IE (1) IE45631B1 (de)
IL (1) IL52353A (de)
LU (1) LU77604A1 (de)
NL (1) NL7707128A (de)
NO (1) NO144848C (de)
PH (2) PH15041A (de)
PT (1) PT66713B (de)
SE (1) SE7707341L (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410548A (en) 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
FR2623804B1 (fr) * 1987-11-27 1990-03-23 Elf Aquitaine Acylation des phenols
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
ES2129434T3 (es) 1991-08-21 1999-06-16 Smith & Nephew Inc Sistema de control de fluidos.
EP1051165A2 (de) 1998-01-26 2000-11-15 Mitokor Schutzmittel für mitochondrien zur behandlung von mitochondrialererkrankungen
DE60008697T2 (de) * 2000-03-28 2005-02-10 Council Of Scientific And Industrial Research Verfahren zur Herstellung von 4-(P-methoxyphenyl)-2-amino-butane und Insektizide
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
TWI545109B (zh) * 2009-05-19 2016-08-11 本州化學工業有限公司 ４-醯基芳烷基苯酚及其衍生物
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104324977A (zh) * 2014-10-22 2015-02-04 无锡市得力手机械有限公司 一种倒立式拉丝机的卸线车
HU231124B1 (hu) * 2016-02-10 2020-12-28 Egis Gyógyszergyár Zrt. Eljárás morfológiailag egységes mirabegron és mirabegron monohidroklorid előállítására
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
IE45631B1 (en) 1982-10-20
NO144848B (no) 1981-08-17
CH627447A5 (en) 1982-01-15
DE2728641A1 (de) 1978-01-05
FR2366272A1 (fr) 1978-04-28
AU2636877A (en) 1979-01-04
PH14332A (en) 1981-05-29
FI771976A (de) 1977-12-26
DK281777A (da) 1977-12-26
IE45631L (en) 1977-12-25
NO144848C (no) 1981-11-25
AT354420B (de) 1979-01-10
LU77604A1 (de) 1978-02-01
CH630068A5 (en) 1982-05-28
PT66713B (en) 1978-11-21
FR2366272B1 (de) 1981-03-06
HK60184A (en) 1984-08-10
GB1544872A (en) 1979-04-25
IL52353A (en) 1981-07-31
AR227126A1 (es) 1982-09-30
PT66713A (en) 1977-07-01
ATA449377A (de) 1979-06-15
CA1091245A (en) 1980-12-09
SE7707341L (sv) 1978-02-13
JPS5321134A (en) 1978-02-27
ES460040A1 (es) 1978-05-01
PH15041A (en) 1982-05-20
IL52353A0 (en) 1977-08-31
DK146386C (da) 1984-03-12
NL7707128A (nl) 1977-12-28
NO772245L (no) 1977-12-28
AR220896A1 (es) 1980-12-15
DK146386B (da) 1983-09-26

Similar Documents

Publication Publication Date Title
JPS52105162A (en) Phthleic derivatives and preparation thereof
AU3062677A (en) Benazepine Derivatives
IL59567A0 (en) Oxiranylmethyltetrahydropyran derivative and its preparation
AU2396577A (en) Phenoxybenzyloxycarbonyl derivatives
AU512626B2 (en) 4-Hydroxyphenylalkanolamine derivatives and preparation thereof
AU2428777A (en) Fluoroacacylresorcin derivatives
AU535880B2 (en) 5h-furanone-2 and 3h-dihydrofuranone-2 derivatives
JPS5312861A (en) Benzimdazole derivative and its preparation
AU3046777A (en) Morphanthridine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU503883B2 (en) Aroyl-phenylindene and aroyl-phenylnapthalene derivatives
JPS52116462A (en) 22oxoopyrrolidine derivative and preparation thereof
AU2628477A (en) Solpenamide derivatives
JPS5291863A (en) Novel 22nitroimidazole derivatives and preparation thereof
JPS52118459A (en) 22furanone derivative and preparation thereof
JPS5312863A (en) Benzodithiolan derivative and its preparation
AU2739077A (en) 4-phenylpipridine derivatives
AU2602377A (en) Hydrazino-Pyridazine Derivatives
AU2973177A (en) 17-spirosiltine derivatives
AU2732577A (en) Triazolobenzazepine derivatives
ZA773762B (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
AU503391B2 (en) Thienothienylcarbonyl-phenyakanoic acids and derivatives
AU520966B2 (en) N-phosphonoacetyl-l-aspartic and derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
JPS5287175A (en) 44arylpiperidine derivative and its preparation